A
Adel Sakr
Researcher at University of Cincinnati
Publications - 79
Citations - 2186
Adel Sakr is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Dosage form & Granulation. The author has an hindex of 27, co-authored 79 publications receiving 2081 citations. Previous affiliations of Adel Sakr include King Saud University & Future University in Egypt.
Papers
More filters
Journal ArticleDOI
Development and Evaluation of a Monolithic Floating Dosage Form for Furosemide
TL;DR: The floating dosage form was found to be a feasible approach in delivering furosemide to the upper gastrointestinal tract to maximize drug absorption and to develop and optimize in vitro a monolithic modified-release dosage form (MMR).
Journal ArticleDOI
Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies.
TL;DR: The results demonstrate that an appropriate receptor fluid, such as MEM, HHBSS, or DMPBS, is required for percutaneous absorption studies in which cutaneous metabolism of the penetrating compound is to be considered.
Journal ArticleDOI
Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets.
TL;DR: Anionic polymers were incorporated into hydroxypropylmethylcellulose (HPMC K100M) to modify the drug release from HPMC matrices to reduce the dissolution profiles and the interaction between propranolol hydrochloride and anionic Polymers was confirmed using the UV difference spectra method.
Journal ArticleDOI
Application of multiple response optimization technique to extended release formulations design
Ehab Hamed,Adel Sakr +1 more
TL;DR: It was concluded that response surface methodology and multiple response optimization could be successfully used to design and optimize extended release formulations with desired preplanned release profile.
Journal ArticleDOI
Characterization of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinyl palmitate to retinol (vitamin A) during percutaneous absorption.
TL;DR: Retinol was the only detectable metabolite of retinyl palmitate in both hairless guinea pig and human skin and may result in significant delivery of retinol into the skin.